Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CanMart was a UK medical cannabis importer and distributor focused on supplying cannabis-based products for medicinal use to pharmacies and clinics. The company positioned itself as an independent supply-chain partner for global medical cannabis producers seeking entry into the UK market, offering bulk import, storage, and wholesale distribution services under UK pharmaceutical licenses. It operated a 30,000-square-foot storage and distribution facility in southeast England and also stated it could store and distribute other pharmaceutical drugs alongside cannabis prescriptions. CanMart was acquired as part of Halo Collective's international cannabis assets and later transferred to Akanda, but the UK legal entity Canmart Ltd is now in liquidation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CanMart.